nach oben

Inflammation Research

Erschienen in:

10.10.2018 | Review

A review of inflammatory mechanism in airway diseases

verfasst von: Parya Aghasafari, Uduak George, Ramana Pidaparti

Erschienen in: Inflammation Research | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Background

Inflammation in the lung is the body’s natural response to injury. It acts to remove harmful stimuli such as pathogens, irritants, and damaged cells and initiate the healing process. Acute and chronic pulmonary inflammation are seen in different respiratory diseases such as; acute respiratory distress syndrome, chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis (CF).

Findings

In this review, we found that inflammatory response in COPD is determined by the activation of epithelial cells and macrophages in the respiratory tract. Epithelial cells and macrophages discharge transforming growth factor-β (TGF-β), which trigger fibroblast proliferation and tissue remodeling. Asthma leads to airway hyper-responsiveness, obstruction, mucus hyper-production, and airway-wall remodeling. Cytokines, allergens, chemokines, and infectious agents are the main stimuli that activate signaling pathways in epithelial cells in asthma. Mutation of the CF transmembrane conductance regulator (CFTR) gene results in CF. Mutations in CFTR influence the lung epithelial innate immune function that leads to exaggerated and ineffective airway inflammation that fails to abolish pulmonary pathogens. We present mechanistic computational models (based on ordinary differential equations, partial differential equations and agent-based models) that have been applied in studying the complex physiological and pathological mechanisms of chronic inflammation in different airway diseases.

Conclusion

The scope of the present review is to explore the inflammatory mechanism in airway diseases and highlight the influence of aging on airways’ inflammation mechanism. The main goal of this review is to encourage research collaborations between experimentalist and modelers to promote our understanding of the physiological and pathological mechanisms that control inflammation in different airway diseases.

Ahmed AU. An overview of inflammation: mechanism and consequences. Frontiers in Biology. 2011;6(4):274–81.

Ward P. Acute lung injury: how the lung inflammatory response works. Eur Respir Soc; 2003;44:22s–23sCrossRef

Lee G, Walser TC, Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med. 2009;15(4):303–7.CrossRefPubMed

Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805–20.CrossRefPubMed

Ortega-Gómez A, Perretti M, Soehnlein O. Resolution of inflammation: an integrated view. EMBO Mol Med. 2013;5(5):661–74.CrossRefPubMedPubMedCentral

Maskrey BH, Megson IL, Whitfield PD, Rossi AG. Mechanisms of resolution of inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):1001–6.CrossRefPubMed

Najar M, Krayem M, Merimi M, Burny A, Meuleman N, Bron D, et al. Insights into inflammatory priming of mesenchymal stromal cells: functional biological impacts. Inflamm Res. 2018. https://doi.org/10.1007/s00011-018-1131-1.CrossRefPubMed

Lumb AB. Nunn’s applied respiratory physiology eBook. Amsterdam: Elsevier Health Sciences; 2016.

Tripathi P, Aggarwal A. NF-kB transcription factor: a key player in the generation of immune response. Curr Sci Bangalore. 2006;90(4):519.

10.

Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med. 2011;17(3–4):293.PubMedCrossRef

11.

Lee I-T, Yang C-M. Inflammatory signalings involved in airway and pulmonary diseases. Mediat Inflamm. 2013;2013:791231.

12.

Moldoveanu B, Otmishi P, Jani P, Walker J, Sarmiento X, Guardiola J, et al. Inflammatory mechanisms in the lung. J Inflamm Res. 2009;2:1–11.PubMed

13.

Nelson RJ. Seasonal immune function and sickness responses. Trends Immunol. 2004;25(4):187–92.CrossRefPubMed

14.

Nelson RJ, Demas GE. Seasonal changes in immune function. Q Rev Biol. 1996:511–48.

15.

Colgan SP, Curtis VF, Campbell EL. The inflammatory tissue microenvironment in IBD. Inflamm Bowel Dis. 2013;19(10):2238.CrossRefPubMed

16.

Dantzer R. Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun. 2001;15(1):7–24.CrossRefPubMed

17.

Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–7.CrossRefPubMed

18.

Chung K, Adcock I. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J. 2008;31(6):1334–56.CrossRefPubMed

19.

Hartupee J, Mann DL. Role of inflammatory cells in fibroblast activation. J Mol Cell Cardiol. 2016;93:143–8.CrossRefPubMed

20.

Baylis D, Bartlett DB, Patel HP, Roberts HC. Understanding how we age: insights into inflammaging. Longev Healthspan. 2013;2(1):8.CrossRefPubMedPubMedCentral

21.

Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev. 2007;65(suppl_3):140-S6.

22.

Brodland GW. How computational models can help unlock biological systems. Semin Cell Dev Biol. 2015;47–48:62–73. https://doi.org/10.1016/j.semcdb.2015.07.001.CrossRefPubMed

23.

Vodovotz Y. Computational modelling of the inflammatory response in trauma, sepsis and wound healing: implications for modelling resilience. Interface Focus. 2014;4(5):20140004. https://doi.org/10.1098/rsfs.2014.0004.CrossRefPubMedPubMedCentral

24.

Fletcher AG, Osterfield M, Baker RE, Shvartsman SY. Vertex models of epithelial morphogenesis. Biophys J. 2014;106(11):2291–304. https://doi.org/10.1016/j.bpj.2013.11.4498.CrossRefPubMedPubMedCentral

25.

Fletcher AG, Cooper F, Baker RE. Mechanocellular models of epithelial morphogenesis. Philos Trans R Soc Lond B Biol Sci. 2017;372(1720). https://doi.org/10.1098/rstb.2015.0519.

26.

George UZ, Bokka KK, Warburton D, Lubkin SR. Quantifying stretch and secretion in the embryonic lung: Implications for morphogenesis. Mech Dev. 2015;138(Pt 3):356–63. https://doi.org/10.1016/j.mod.2015.07.003.CrossRefPubMedPubMedCentral

27.

Lubkin SR, Murray JD. A mechanism for early branching in lung morphogenesis. J Math Biol. 1995;34(1):77–94.CrossRefPubMed

28.

Clément R, Douady S, Mauroy B. Branching geometry induced by lung self-regulated growth. Phys Biol. 2012;9(6):066006. https://doi.org/10.1088/1478-3975/9/6/066006.CrossRefPubMed

29.

Iber D, Menshykau D. The control of branching morphogenesis. Open Biol. 2013;3(9):130088. https://doi.org/10.1098/rsob.130088.CrossRefPubMedPubMedCentral

30.

Varner VD, Nelson CM. Computational models of airway branching morphogenesis. Semin Cell Dev Biol. 2017;67:170–6. https://doi.org/10.1016/j.semcdb.2016.06.003.CrossRefPubMed

31.

Tran K, Smith NP, Loiselle DS, Crampin EJ. A metabolite-sensitive, thermodynamically constrained model of cardiac cross-bridge cycling: implications for force development during ischemia. Biophys J. 2010;98(2):267–76. https://doi.org/10.1016/j.bpj.2009.10.011.CrossRefPubMedPubMedCentral

32.

Washio T, Okada JI, Sugiura S, Hisada T. Approximation for cooperative interactions of a spatially-detailed cardiac sarcomere model. Cell Mol Bioeng. 2012;5(1):113–26. https://doi.org/10.1007/s12195-011-0219-2.CrossRefPubMed

33.

Dewan S, McCabe KJ, Regnier M, McCulloch AD. Insights and challenges of multi-scale modeling of sarcomere mechanics in cTn and Tm DCM mutants-genotype to cellular phenotype. Front Physiol. 2017;8:151. https://doi.org/10.3389/fphys.2017.00151.CrossRefPubMedPubMedCentral

34.

Constantino J, Hu Y, Trayanova NA. A computational approach to understanding the cardiac electromechanical activation sequence in the normal and failing heart, with translation to the clinical practice of CRT. Prog Biophys Mol Biol. 2012;110(2–3):372–9. https://doi.org/10.1016/j.pbiomolbio.2012.07.009.CrossRefPubMedPubMedCentral

35.

Lopez-Perez A, Sebastian R, Ferrero JM. Three-dimensional cardiac computational modelling: methods, features and applications. Biomed Eng Online. 2015;14:35. https://doi.org/10.1186/s12938-015-0033-5.CrossRefPubMedPubMedCentral

36.

Trayanova NA. Whole-heart modeling: applications to cardiac electrophysiology and electromechanics. Circ Res. 2011;108(1):113–28. https://doi.org/10.1161/CIRCRESAHA.110.223610.CrossRefPubMedPubMedCentral

37.

Friedrich J, Lengyel M. Goal-directed decision making with spiking neurons. J Neurosci. 2016;36(5):1529–46. https://doi.org/10.1523/JNEUROSCI.2854-15.2016.CrossRefPubMedPubMedCentral

38.

Rustichini A, Conen KE, Cai X, Padoa-Schioppa C. Optimal coding and neuronal adaptation in economic decisions. Nat Commun. 2017;8(1):1208. https://doi.org/10.1038/s41467-017-01373-y.CrossRefPubMedPubMedCentral

39.

Cumming BD, McElwain DL, Upton Z. A mathematical model of wound healing and subsequent scarring. J R Soc Interface. 2010;7(42):19–34. https://doi.org/10.1098/rsif.2008.0536.CrossRefPubMed

40.

Flegg JA, Byrne HM, Flegg MB, McElwain DL. Wound healing angiogenesis: the clinical implications of a simple mathematical model. J Theor Biol. 2012;300:309–16. https://doi.org/10.1016/j.jtbi.2012.01.043.CrossRefPubMed

41.

Sherratt JA, Dallon JC. Theoretical models of wound healing: past successes and future challenges. C R Biol. 2002;325(5):557–64.CrossRefPubMed

42.

Patel AA, Gawlinski ET, Lemieux SK, Gatenby RA. A cellular automaton model of early tumor growth and invasion. J Theor Biol. 2001;213(3):315–31. https://doi.org/10.1006/jtbi.2001.2385.CrossRefPubMed

43.

Powathil G, Kohandel M, Sivaloganathan S, Oza A, Milosevic M. Mathematical modeling of brain tumors: effects of radiotherapy and chemotherapy. Phys Med Biol. 2007;52(11):3291–306. https://doi.org/10.1088/0031-9155/52/11/023.CrossRefPubMed

44.

Anderson AR, Chaplain MA. Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull Math Biol. 1998;60(5):857–99. https://doi.org/10.1006/bulm.1998.0042.CrossRefPubMed

45.

McDougall SR, Anderson AR, Chaplain MA. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. J Theor Biol. 2006;241(3):564–89. https://doi.org/10.1016/j.jtbi.2005.12.022.CrossRefPubMed

46.

Vodovotz Y, Chow CC, Bartels J, Lagoa C, Prince JM, Levy RM, et al. In silico models of acute inflammation in animals. Shock. 2006;26(3):235–44. https://doi.org/10.1097/01.shk.0000225413.13866.fo.CrossRefPubMed

47.

Day J, Rubin J, Vodovotz Y, Chow CC, Reynolds A, Clermont G. A reduced mathematical model of the acute inflammatory response II. Capturing scenarios of repeated endotoxin administration. J Theor Biol. 2006;242(1):237–56. https://doi.org/10.1016/j.jtbi.2006.02.015.CrossRefPubMed

48.

Reynolds A, Rubin J, Clermont G, Day J, Vodovotz Y, Bard Ermentrout G. A reduced mathematical model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation. J Theor Biol. 2006;242(1):220–36. https://doi.org/10.1016/j.jtbi.2006.02.016.CrossRefPubMed

49.

Dong X, Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. Agent-based modeling of endotoxin-induced acute inflammatory response in human blood leukocytes. PLoS One. 2010;5(2):e9249. https://doi.org/10.1371/journal.pone.0009249.CrossRefPubMedPubMedCentral

50.

Kumar R, Clermont G, Vodovotz Y, Chow CC. The dynamics of acute inflammation. J Theor Biol. 2004;230(2):145–55. https://doi.org/10.1016/j.jtbi.2004.04.044.CrossRefPubMed

51.

Álvarez E, Toledano V, Morilla F, Hernández-Jiménez E, Cubillos-Zapata C, Varela-Serrano A, et al. A system dynamics model to predict the human monocyte response to endotoxins. Front Immunol. 2017;8:915. https://doi.org/10.3389/fimmu.2017.00915.CrossRefPubMedPubMedCentral

52.

Brown D, Namas RA, Almahmoud K, Zaaqoq A, Sarkar J, Barclay DA, et al. Trauma in silico: Individual-specific mathematical models and virtual clinical populations. Sci Transl Med. 2015;7(285):285ra61. https://doi.org/10.1126/scitranslmed.aaa3636.CrossRefPubMed

53.

Abboud A, Mi Q, Puccio A, Okonkwo D, Buliga M, Constantine G, et al. Inflammation following traumatic brain injury in humans: insights from data-driven and mechanistic models into survival and death. Front Pharmacol. 2016;7:342. https://doi.org/10.3389/fphar.2016.00342.CrossRefPubMedPubMedCentral

54.

Barber J, Tronzo M, Harold Horvat C, Clermont G, Upperman J, Vodovotz Y, et al. A three-dimensional mathematical and computational model of necrotizing enterocolitis. J Theor Biol. 2013;322:17–32. https://doi.org/10.1016/j.jtbi.2012.11.018.CrossRefPubMed

55.

Swan AJ, Tawhai MH. Evidence for minimal oxygen heterogeneity in the healthy human pulmonary acinus. J Appl Physiol (1985). 2011;110(2):528–37. https://doi.org/10.1152/japplphysiol.00888.2010.CrossRef

56.

Hewitt TJ, Hattler BG, Federspiel WJ. A mathematical model of gas exchange in an intravenous membrane oxygenator. Ann Biomed Eng. 1998;26(1):166–78.CrossRefPubMed

57.

Brighenti C, Gnudi G, Avanzolini G. A simulation model of the oxygen alveolo-capillary exchange in normal and pathological conditions. Physiol Meas. 2003;24(2):261–75.CrossRefPubMed

58.

De Backer JW, Vos WG, Gorlé CD, Germonpré P, Partoens B, Wuyts FL, et al. Flow analyses in the lower airways: patient-specific model and boundary conditions. Med Eng Phys. 2008;30(7):872–9. https://doi.org/10.1016/j.medengphy.2007.11.002.CrossRefPubMed

59.

Aghasafari P, Bin M, Ibrahim I, Pidaparti R. Strain-induced inflammation in pulmonary alveolar tissue due to mechanical ventilation. Biomech Model Mechanobiol. 2017. https://doi.org/10.1007/s10237-017-0879-5.CrossRefPubMed

60.

Pidaparti RM, Koombua K. Tissue strains induced in airways due to mechanical ventilation. Mol Cell Biomech. 2011;8(2):149–68.PubMed

61.

Pidaparti RM, Swanson J. Effect of mechanical ventilation waveforms on airway wall shear. J Med Eng Technol. 2015;39(1):1–8. https://doi.org/10.3109/03091902.2014.968675.CrossRefPubMed

62.

Yin Y, Choi J, Hoffman EA, Tawhai MH, Lin CL. A multiscale MDCT image-based breathing lung model with time-varying regional ventilation. J Comput Phys. 2013;244:168–92. https://doi.org/10.1016/j.jcp.2012.12.007.CrossRefPubMed

63.

Swan AJ, Clark AR, Tawhai MH. A computational model of the topographic distribution of ventilation in healthy human lungs. J Theor Biol. 2012;300:222–31. https://doi.org/10.1016/j.jtbi.2012.01.042.CrossRefPubMedPubMedCentral

64.

Roth CJ, Yoshihara L, Ismail M, Wall WA. Computational modelling of the respiratory system: discussion of coupled modeling approaches and two recent extensions. Comput Methods Appl Mech Eng. 2017;314:473–93.CrossRef

65.

Burrowes KS, Clark AR, Tawhai MH. Blood flow redistribution and ventilation-perfusion mismatch during embolic pulmonary arterial occlusion. Pulm Circ. 2011;1(3):365–76. https://doi.org/10.4103/2045-8932.87302.CrossRefPubMedPubMedCentral

66.

Tang BT, Fonte TA, Chan FP, Tsao PS, Feinstein JA, Taylor CA. Three-dimensional hemodynamics in the human pulmonary arteries under resting and exercise conditions. Ann Biomed Eng. 2011;39(1):347–58. https://doi.org/10.1007/s10439-010-0124-1.CrossRefPubMed

67.

Rausch SM, Martin C, Bornemann PB, Uhlig S, Wall WA. Material model of lung parenchyma based on living precision-cut lung slice testing. J Mech Behav Biomed Mater. 2011;4(4):583–92. https://doi.org/10.1016/j.jmbbm.2011.01.006.CrossRefPubMed

68.

Berger L, Bordas R, Burrowes K, Grau V, Tavener S, Kay D. A poroelastic model coupled to a fluid network with applications in lung modelling. Int J Numer Method Biomed Eng. 2016;32(1):e02731. https://doi.org/10.1002/cnm.2731.CrossRefPubMed

69.

Burrowes KS, Doel T, Brightling C. Computational modeling of the obstructive lung diseases asthma and COPD. J Transl Med. 2014;12(Suppl 2):5. https://doi.org/10.1186/1479-5876-12-S2-S5.CrossRef

70.

Kim J, Heise RL, Reynolds AM, Pidaparti RM. Quantification of age-related lung tissue mechanics under mechanical ventilation. Med Sci (Basel). 2017. https://doi.org/10.3390/medsci5040021.CrossRef

71.

Kim J, Heise RL, Reynolds AM, Pidaparti RM. Aging effects on airflow dynamics and lung function in human bronchioles. PLoS One. 2017;12(8):e0183654. https://doi.org/10.1371/journal.pone.0183654.CrossRefPubMedPubMedCentral

72.

Cheng YH, You SH, Lin YJ, Chen SC, Chen WY, Chou WC, et al. Mathematical modeling of postcoinfection with influenza A virus and Streptococcus pneumoniae, with implications for pneumonia and COPD-risk assessment. Int J Chron Obstruct Pulmon Dis. 2017;12:1973–88. https://doi.org/10.2147/COPD.S138295.CrossRefPubMedPubMedCentral

73.

Cox LA. A causal model of chronic obstructive pulmonary disease (COPD) risk. Risk Anal. 2011;31(1):38–62. https://doi.org/10.1111/j.1539-6924.2010.01487.x.CrossRefPubMed

74.

Brown BN, Price IM, Toapanta FR, DeAlmeida DR, Wiley CA, Ross TM, et al. An agent-based model of inflammation and fibrosis following particulate exposure in the lung. Math Biosci. 2011;231(2):186–96. https://doi.org/10.1016/j.mbs.2011.03.005.CrossRefPubMedPubMedCentral

75.

Kim Y, Lee S, Kim YS, Lawler S, Gho YS, Kim YK, et al. Regulation of Th1/Th2 cells in asthma development: a mathematical model. Math Biosci Eng. 2013;10(4):1095–133.CrossRefPubMed

76.

Reynolds A, Koombua K, Pidaparti RM, Ward KR. Cellular automata modeling of pulmonary inflammation. Mol Cell Biomech. 2012;9(2):141–56.PubMed

77.

Ibrahim I, Oruganti SV, Pidaparti R. Simulation of Healing Threshold in Strain-Induced Inflammation through a discrete informatics model. IEEE J Biomed Health Inform. 2017. https://doi.org/10.1109/JBHI.2017.2669729.CrossRefPubMed

78.

W GA,M. S. C. Agent-based modeling approaches to multi-scale systems biology: an example agent-based model of acute pulmonary inflammation. In: Prokop A, Csukás B, editors. Systems biology. Dordrecht: Springer; 2013. pp. 429–61.

79.

Lane N, Robins RA, Corne J, Fairclough L. Regulation in chronic obstructive pulmonary disease: the role of regulatory T-cells and Th17 cells. Clin Sci. 2010;119(2):75–86.CrossRef

80.

Donnelly LE, Barnes PJ. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease. Trends Pharmacol Sci. 2006;27(10):546–53.CrossRefPubMed

81.

Traynor TR, Herring AC, Dorf ME, Kuziel WA, Toews GB, Huffnagle GB. Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J Immunol. 2002;168(9):4659–66.CrossRefPubMed

82.

Barnes PJ. Cellular and molecular mechanisms of asthma and COPD. Clin Sci. 2017;131(13):1541–58.CrossRef

83.

Suki B, Lutchen KR, Ingenito EP. On the progressive nature of emphysema: roles of proteases, inflammation, and mechanical forces. Am J Respir Crit Care Med. 2003;168(5):516–21.CrossRefPubMed

84.

Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8(3):183–92.CrossRefPubMed

85.

Chung KF. The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(4):347–54.CrossRefPubMedPubMedCentral

86.

Hutchinson AT, Vlahos R, Bozinovski S. Role of alveolar macrophages in chronic obstructive pulmonary disease. Front Immunol. 2014;5:435.

87.

Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011;378(9795):1015–26.CrossRefPubMed

88.

Kudo M, Ishigatsubo Y, Aoki I. Pathology of asthma. Front Microbiol. 2013;4:263.CrossRefPubMedPubMedCentral

89.

Chung KF. Targeting the interleukin pathway in the treatment of asthma. Lancet. 2015;386(9998):1086–96.CrossRefPubMed

90.

Wang Y, Bai C, Li K, Adler KB, Wang X. Role of airway epithelial cells in development of asthma and allergic rhinitis. Respir Med. 2008;102(7):949–55.CrossRefPubMed

91.

Holgate ST. Innate and adaptive immune responses in asthma. Nat Med. 2012;18(5):673–83.CrossRefPubMed

92.

Kubo T, Morita H, Sugita K, Akdis CA. Introduction to mechanisms of allergic diseases. Middleton’s allergy essentials. Amsterdam: Elsevier; 2017. pp. 1–27.

93.

Murdoch JR, Lloyd CM. Chronic inflammation and asthma. Mutat Res Fundam Mol Mech Mutagen. 2010;690(1):24–39.CrossRef

94.

Carr TF, Berdnikovs S, Simon H-U, Bochner BS, Rosenwasser LJ. Eosinophilic bioactivities in severe asthma. World Allergy Organ J. 2016;9(1):21.CrossRefPubMedPubMedCentral

95.

Barnig C, Frossard N, Levy BD. Towards targeting resolution pathways of airway inflammation in asthma. Pharmacol Ther. 2018;186:98–113CrossRefPubMed

96.

Barnig C, Levy BD. Innate immunity is a key factor for the resolution of inflammation in asthma. Eur Respir Rev. 2015;24(135):141–53.CrossRefPubMedPubMedCentral

97.

Martín-Orozco E, Norte-Muñoz M, Martínez-García J. Regulatory T cells in allergy and asthma. Front Pediatr. 2017;5.

98.

Ross R. Platelet-derived growth factor. Lancet. 1989;333(8648):1179–82.CrossRef

99.

Heldin C-H. Structural and functional studies on platelet-derived growth factor. EMBO J. 1992;11(12):4251.CrossRefPubMedPubMedCentral

100.

Dolgachev VA, Ullenbruch MR, Lukacs NW, Phan SH. Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling. Am J Pathol. 2009;174(2):390–400.CrossRefPubMedPubMedCentral

101.

Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med. 2004;10(10):1095–103.CrossRefPubMedPubMedCentral

102.

Bhandari V, Choo-Wing R, Chapoval SP, Lee CG, Tang C, Kim Y, et al. Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung. Proc Natl Acad Sci. 2006;103(29):11021–6.CrossRefPubMedPubMedCentral

103.

McMillan SJ, Kearley J, Campbell JD, Zhu X-W, Larbi KY, Shipley JM, et al. Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol. 2004;172(4):2586–94.CrossRefPubMed

104.

Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1. J Exp Med. 2001;194(6):809–22.CrossRefPubMedPubMedCentral

105.

Cutting GR. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet. 2015;16(1):45.CrossRefPubMed

106.

Cutting GR, Engelhardt J, Zeitlin PL. Genetics and pathophysiology of cystic fibrosis. Kendig’s disorders of the respiratory tract in children (9th Edition). Amsterdam: Elsevier; 2019. pp. 757–68.e6.

107.

Collawn JF, Matalon S. CFTR and lung homeostasis. Am J Physiol Lung Cell Mol Physiol. 2014;307(12):L917-L23.CrossRef

108.

Muir A, Soong G, Sokol S, Reddy B, Gomez MI, van Heeckeren A, et al. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol. 2004;30(6):777–83.CrossRefPubMed

109.

Chirico V, Lacquaniti A, Leonardi S, Grasso L, Rotolo N, Romano C, et al. Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection. Clin Microbiol Infect. 2015;21(4):368.e1–e9.CrossRef

110.

Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med. 2012;18(4):509–19.CrossRefPubMedPubMedCentral

111.

McCuaig S, Martin JG. How the airway smooth muscle in cystic fibrosis reacts in proinflammatory conditions: implications for airway hyper-responsiveness and asthma in cystic fibrosis. Lancet Respir Med. 2013;1(2):137–47.CrossRefPubMed

112.

Dekkers JF, van der Ent CK, Kalkhoven E, Beekman JM. PPARγ as a therapeutic target in cystic fibrosis. Trends Mol Med. 2012;18(5):283–91.CrossRefPubMed

113.

Bals R, Weiner DJ, Wilson JM. The innate immune system in cystic fibrosis lung disease. J Clin Investig. 1999;103(3):303–7.CrossRefPubMedPubMedCentral

114.

Tang AC, Turvey SE, Alves MP, Regamey N, Tümmler B, Hartl D. Current concepts: host–pathogen interactions in cystic fibrosis airways disease. Eur Respir Rev. 2014;23(133):320–32.CrossRefPubMed

115.

Hilliard TN, Regamey N, Shute JK, Nicholson AG, Alton EW, Bush A, et al. Airway remodelling in children with cystic fibrosis. Thorax. 2007;62(12):1074–80.CrossRefPubMedPubMedCentral

116.

Murphy G, Docherty AJ. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol. 1992;7:120-.CrossRefPubMed

117.

Ratjen F, Hartog C, Paul K, Wermelt J, Braun J. Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha. Thorax. 2002;57(11):930–4.CrossRefPubMedPubMedCentral

118.

Courtney J, Ennis M, Elborn J. Cytokines and inflammatory mediators in cystic fibrosis. J Cyst Fibros. 2004;3(4):223–31.CrossRefPubMed

119.

Hardie WD, Bejarano PA, Miller MA, Yankaskas JR, Ritter JH, Whitsett JA, et al. Immunolocalization of transforming growth factor α and epidermal growth factor receptor in lungs of patients with cystic fibrosis. Pediatr Dev Pathol. 1999;2(5):415–23.CrossRefPubMed

120.

Booth BW, Adler KB, Bonner JC, Tournier F, Martin LD. Interleukin-13 induces proliferation of human airway epithelial cells in vitro via a mechanism mediated by transforming growth factor-α. Am J Respir Cell Mol Biol. 2001;25(6):739–43.CrossRefPubMed

121.

Spannhake EW. Interactions of pollutants with the epithelium. In: The pulmonary epithelium in health and disease. John Wiley & Sons; 2008. pp 275–99.

122.

López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194–217.CrossRefPubMedPubMedCentral

123.

Naylor R, Baker D, Van Deursen J. Senescent cells: a novel therapeutic target for aging and age-related diseases. Clin Pharmacol Ther. 2013;93(1):105–16.CrossRefPubMed

124.

Hosgood HD, Menashe I, He X, Chanock S, Lan Q. PTEN identified as important risk factor of chronic obstructive pulmonary disease. Respir Med. 2009;103(12):1866–70.CrossRefPubMedPubMedCentral

125.

Mercado N, Ito K, Barnes PJ. Accelerated ageing of the lung in COPD: new concepts. Thorax. 2015. https://doi.org/10.1136/thoraxjnl-2014-206084.CrossRefPubMed

126.

Holzenberger M, Dupont J, Ducos B, Leneuve P, Géloën A, Even PC, et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 2003;421(6919):182–7.CrossRefPubMed

127.

Kapahi P, Zid BM, Harper T, Koslover D, Sapin V, Benzer S. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol. 2004;14(10):885–90.CrossRefPubMedPubMedCentral

128.

Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature. 2013;493(7432):338–45.CrossRefPubMedPubMedCentral

129.

Ito K, Colley T, Mercado N. Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease. Int J Chron Obstruct Pulmon Dis. 2012;7(4):641–52.CrossRefPubMedPubMedCentral

130.

Hahn DR, Na C-L, Weaver TE. Reserve autophagic capacity in alveolar epithelia provides a replicative niche for influenza A virus. Am J Respir Cell Mol Biol. 2014;51(3):400–12.CrossRefPubMedPubMedCentral

131.

Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. CHEST J. 2009;135(1):173–80.CrossRef

132.

Aoshiba K, Zhou F, Tsuji T, Nagai A. DNA damage as a molecular link in the pathogenesis of COPD in smokers. Eur Respir J. 2012;39(6):1368–76.CrossRefPubMed

133.

Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2000;356(9240):1480–5. https://doi.org/10.1016/S0140-6736(00)02872-5.CrossRefPubMed

134.

Athanazio R. Airway disease: similarities and differences between asthma, COPD and bronchiectasis. Clinics (Sao Paulo). 2012;67(11):1335–43.CrossRef

135.

Sutherland ER, Martin RJ. Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma. J Allergy Clin Immunol. 2003;112(5):819–27. https://doi.org/10.1016/S0091 (quiz 28).CrossRefPubMed

136.

Cantin AM, Hartl D, Konstan MW, Chmiel JF. Inflammation in cystic fibrosis lung disease: pathogenesis and therapy. J Cyst Fibros. 2015;14(4):419–30. https://doi.org/10.1016/j.jcf.2015.03.003.CrossRefPubMed

137.

Stankiewicz W, Dabrowski MP, Chcialowski A, Plusa T. Cellular and cytokine immunoregulation in patients with chronic obstructive pulmonary disease and bronchial asthma. Mediators Inflamm. 2002;11(5):307–12. https://doi.org/10.1080/09629350210000015719.CrossRefPubMedPubMedCentral

138.

Burrows B, Knudson RJ, Cline MG, Lebowitz MD. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis. 1977;115(2):195–205. https://doi.org/10.1164/arrd.1977.115.2.195.CrossRefPubMed

139.

Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218–24. https://doi.org/10.1164/rccm.200711-1754OC.CrossRefPubMed

140.

Voit EO. A systems-theoretical framework for health and disease: inflammation and preconditioning from an abstract modeling point of view. Math Biosci. 2009;217(1):11–8. https://doi.org/10.1016/j.mbs.2008.09.005.CrossRefPubMed

141.

Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):4–9. https://doi.org/10.1093/gerona/glu057.CrossRef

142.

Medzhitov R. Inflammation. new adventures of an old flame. Cell. 2010;140(6):771–6. https://doi.org/10.1016/j.cell.2010.03.006.CrossRefPubMed

143.

Goldstein B, Faeder JR, Hlavacek WS. Mathematical and computational models of immune-receptor signalling. Nat Rev Immunol. 2004;4(6):445–56. https://doi.org/10.1038/nri1374.CrossRefPubMed

144.

Li NY, Verdolini K, Clermont G, Mi Q, Rubinstein EN, Hebda PA, et al. A patient-specific in silico model of inflammation and healing tested in acute vocal fold injury. PLoS One. 2008;3(7):e2789. https://doi.org/10.1371/journal.pone.0002789.CrossRefPubMedPubMedCentral

145.

Brauer F, Kris C. Dynamical systems for biological modeling: an introduction. Boca Raton: CRC Press; 2015.

146.

Pigozzo AB, Macedo GC, Santos RW, Lobosco M. On the computational modeling of the innate immune system. BMC Bioinform. 2013;14(Suppl 6):7. https://doi.org/10.1186/1471-2105-14-S6-S7.CrossRef

147.

Lee J, Adler FR, Kim PS. A mathematical model for the macrophage response to respiratory viral infection in normal and asthmatic conditions. Bull Math Biol. 2017. https://doi.org/10.1007/s11538-017-0315-0.CrossRefPubMed

148.

Chernyavsky IL, Croisier H, Chapman LA, Kimpton LS, Hiorns JE, Brook BS, et al. The role of inflammation resolution speed in airway smooth muscle mass accumulation in asthma: insight from a theoretical model. PLoS One. 2014;9(3):e90162. https://doi.org/10.1371/journal.pone.0090162.CrossRefPubMedPubMedCentral

149.

James AL, Elliot JG, Jones RL, Carroll ML, Mauad T, Bai TR, et al. Airway smooth muscle hypertrophy and hyperplasia in asthma. Am J Respir Crit Care Med. 2012;185(10):1058–64. https://doi.org/10.1164/rccm.201110-1849OC.CrossRefPubMed

150.

Brook BS, Peel SE, Hall IP, Politi AZ, Sneyd J, Bai Y, et al. A biomechanical model of agonist-initiated contraction in the asthmatic airway. Respir Physiol Neurobiol. 2010;170(1):44–58. https://doi.org/10.1016/j.resp.2009.11.006.CrossRefPubMed

151.

Moulton DE, Goriely A. Possible role of differential growth in airway wall remodeling in asthma. J Appl Physiol (1985). 2011;110(4):1003–12. https://doi.org/10.1152/japplphysiol.00991.2010.CrossRef

152.

Schlender A, Alperin PE, Grossman HL, Sutherland ER. Modeling the impact of increased adherence to asthma therapy. PLoS One. 2012;7(12):e51139. https://doi.org/10.1371/journal.pone.0051139.CrossRefPubMedPubMedCentral

153.

Smith AM, Adler FR, Ribeiro RM, Gutenkunst RN, McAuley JL, McCullers JA, et al. Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae. PLoS Pathog. 2013;9(3):e1003238. https://doi.org/10.1371/journal.ppat.1003238.CrossRefPubMedPubMedCentral

154.

Smith AM, McCullers JA, Adler FR. Mathematical model of a three-stage innate immune response to a pneumococcal lung infection. J Theor Biol. 2011;276(1):106–16. https://doi.org/10.1016/j.jtbi.2011.01.052.CrossRefPubMedPubMedCentral

155.

Markovetz MR, Corcoran TE, Locke LW, Myerburg MM, Pilewski JM, Parker RS. A physiologically-motivated compartment-based model of the effect of inhaled hypertonic saline on mucociliary clearance and liquid transport in cystic fibrosis. PLoS One. 2014;9(11):e111972. https://doi.org/10.1371/journal.pone.0111972.CrossRefPubMedPubMedCentral

156.

157.

Donovan GM. Multiscale mathematical models of airway constriction and disease. Pulm Pharmacol Ther. 2011;24(5):533–9. https://doi.org/10.1016/j.pupt.2011.01.003.CrossRefPubMedPubMedCentral

158.

Politi AZ, Donovan GM, Tawhai MH, Sanderson MJ, Lauzon AM, Bates JH, et al. A multiscale, spatially distributed model of asthmatic airway hyper-responsiveness. J Theor Biol. 2010;266(4):614–24. https://doi.org/10.1016/j.jtbi.2010.07.032.CrossRefPubMedPubMedCentral

159.

Venegas JG, Winkler T, Musch G, Vidal Melo MF, Layfield D, Tgavalekos N, et al. Self-organized patchiness in asthma as a prelude to catastrophic shifts. Nature. 2005;434(7034):777–82. https://doi.org/10.1038/nature03490.CrossRefPubMed

160.

Amin SD, Majumdar A, Frey U, Suki B. Modeling the dynamics of airway constriction: effects of agonist transport and binding. J Appl Physiol (1985). 2010;109(2):553–63. https://doi.org/10.1152/japplphysiol.01111.2009.CrossRef

161.

Cilfone NA, Perry CR, Kirschner DE, Linderman JJ. Multi-scale modeling predicts a balance of tumor necrosis factor-α and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection. PLoS One. 2013;8(7):e68680. https://doi.org/10.1371/journal.pone.0068680.CrossRefPubMedPubMedCentral

162.

Fallahi-Sichani M, El-Kebir M, Marino S, Kirschner DE, Linderman JJ. Multiscale computational modeling reveals a critical role for TNF-α receptor 1 dynamics in tuberculosis granuloma formation. J Immunol. 2011;186(6):3472–83. https://doi.org/10.4049/jimmunol.1003299.CrossRefPubMed

163.

Ceresa M, Olivares AL, Fernandez Suelves S, Noailly J, Gonzalez Ballester MA. Multi-scale immunological and biomechanical model of emphysema progression. Conf Proc IEEE Eng Med Biol Soc. 2017;2017:2712–5. https://doi.org/10.1109/EMBC.2017.8037417.CrossRef

164.

Ceresa M, Olivares AL, Noailly J, González Ballester MA. Coupled immunological and biomechanical model of emphysema progression. Front Physiol. 2018;9:388. https://doi.org/10.3389/fphys.2018.00388.CrossRefPubMedPubMedCentral

165.

Cilfone NA, Kirschner DE, Linderman JJ. Strategies for efficient numerical implementation of hybrid multi-scale agent-based models to describe biological systems. Cell Mol Bioeng. 2015;8(1):119–36. https://doi.org/10.1007/s12195-014-0363-6.CrossRefPubMed

166.

Marino S, Kirschner DE. A multi-compartment hybrid computational model predicts key roles for dendritic cells in tuberculosis infection. Computation (Basel). 2016. https://doi.org/10.3390/computation4040039.CrossRef

167.

Warsinske HC, Wheaton AK, Kim KK, Linderman JJ, Moore BB, Kirschner DE. Computational modeling predicts simultaneous targeting of fibroblasts and epithelial cells is necessary for treatment of pulmonary fibrosis. Front Pharmacol. 2016;7:183. https://doi.org/10.3389/fphar.2016.00183.CrossRefPubMedPubMedCentral

168.

Bouchnita A, Bocharov G, Meyerhans A, Volpert V. Hybrid approach to model the spatial regulation of T cell responses. BMC Immunol. 2017;18(Suppl 1):29. https://doi.org/10.1186/s12865-017-0205-0.CrossRefPubMedPubMedCentral

169.

Cevenini E, Caruso C, Candore G, Capri M, Nuzzo D, Duro G, et al. Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr Pharm Des. 2010;16(6):609–18.CrossRefPubMed

170.

Weinberg EJ, Schoen FJ, Mofrad MR. A computational model of aging and calcification in the aortic heart valve. PLoS One. 2009;4(6):e5960. https://doi.org/10.1371/journal.pone.0005960.CrossRefPubMedPubMedCentral

171.

Mc Auley MT, Mooney KM. Computationally modeling lipid metabolism and aging: a mini-review. Comput Struct Biotechnol J. 2015;13:38–46. https://doi.org/10.1016/j.csbj.2014.11.006.CrossRefPubMed

172.

Mooney KM, Morgan AE, Mc Auley MT. Aging and computational systems biology. Wiley Interdiscip Rev Syst Biol Med. 2016;8(2):123–39. https://doi.org/10.1002/wsbm.1328.CrossRefPubMed

173.

Mc Auley MT, Mooney KM. Computational systems biology for aging research. Interdiscip Top Gerontol. 2015;40:35–48. https://doi.org/10.1159/000364928.CrossRefPubMed

174.

Witten TM. Modeling cellular aging: an introduction—mathematical and computational approaches. In: Rattan SIS, Hayflick L, editors. Cellular ageing and replicative senescence. vol 4. New York: Springer International Publishing; 2016. pp. 117–41.

175.

Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428–35. https://doi.org/10.1038/nature07201.CrossRefPubMed

176.

Weber GF, Chousterman BG, He S, Fenn AM, Nairz M, Anzai A, et al. Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis. Science. 2015;347(6227):1260–5. https://doi.org/10.1126/science.aaa4268.CrossRefPubMedPubMedCentral

177.

Serhan CN, Chiang N, Dalli J. The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution. Semin Immunol. 2015;27(3):200–15. https://doi.org/10.1016/j.smim.2015.03.004.CrossRefPubMedPubMedCentral

178.

Chiang N, Dalli J, Colas RA, Serhan CN. Identification of resolvin D2 receptor mediating resolution of infections and organ protection. J Exp Med. 2015;212(8):1203–17. https://doi.org/10.1084/jem.20150225.CrossRefPubMedPubMedCentral

179.

Medzhitov R, Shevach EM, Trinchieri G, Mellor AL, Munn DH, Gordon S, et al. Highlights of 10 years of immunology in nature reviews immunology. Nat Rev Immunol. 2011;11(10):693–702. https://doi.org/10.1038/nri3063.CrossRefPubMedPubMedCentral

180.

Reyes M, Quintanilla C, Burrows R, Blanco E, Cifuentes M, Gahagan S. Obesity is associated with acute inflammation in a sample of adolescents. Pediatr Diabetes. 2015;16(2):109–16. https://doi.org/10.1111/pedi.12129.CrossRefPubMed

181.

Wang X, Zhu M, Hjorth E, Cortés-Toro V, Eyjolfsdottir H, Graff C, et al. Resolution of inflammation is altered in Alzheimer’s disease. Alzheimers Dement. 2015;11(1):40–50. https://doi.org/10.1016/j.jalz.2013.12.024.CrossRefPubMed

182.

Kotas ME, Medzhitov R. Homeostasis, inflammation, and disease susceptibility. Cell. 2015;160(5):816–27. https://doi.org/10.1016/j.cell.2015.02.010.CrossRefPubMedPubMedCentral

Titel: A review of inflammatory mechanism in airway diseases
verfasst von: Parya Aghasafari
Uduak George
Ramana Pidaparti
Publikationsdatum: 10.10.2018
Verlag: Springer International Publishing
Erschienen in: Inflammation Research / Ausgabe 1/2019
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI: https://doi.org/10.1007/s00011-018-1191-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Background

Findings

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Metabolites of prostaglandin synthases as potential biomarkers of Lyme disease severity and symptom resolution

C-reactive protein as a biomarker of severe H1N1 influenza

Pre-eclampsia: the role of highly active antiretroviral therapy and immune markers

CD8+ T cell/IL-33/ILC2 axis exacerbates the liver injury in Con A-induced hepatitis in T cell-transferred Rag2-deficient mice

Altered regulation of the T-cell system in patients with CRPS